Collecting and Protecting Patient Data

Date June 13, 2017

The goal of any clinical trial or post marketing surveillance effort (Phase IV studies) is to collect patient level data to evaluate a drug’s effectiveness while protecting the identity of the patient from those researcher evaluating the results of the trail. The challenge in this age of readily accessible personal data is to identify ways …

Managing Medication Recalls with ADLT™

Date June 12, 2017

Whether you are a pharmacist, wholesaler, or manufacturer, you realize that the medication recall process requires drastic improvement. As described by Dr. Darryl Glover, Pharm. D MBA: “I have experienced this first hand as a pharmacist. There were several times when patients would come to the pharmacy and tell me they heard their medication was …

Blockchain for Pharma Series – Part 3

Date January 17, 2017

In this series, participants from the 16 November 2016, Pharma Blockchain Bootcamp, lend their insights into the future of distributed ledger technology. Source: IEEE Learn More Here!

The Information Supply Chain: Facilitating Outcome Based Pricing

Date August 17, 2016

According to an August 9th, 2016 article by Reuters, Analysis-Future of Drug Pricing: Paying for Benefits not per Pill, it was stated “..shifting the overall industry to a new model (paying for clinical outcomes) requires improvements in data collection and a change in thinking..”. The article later stated that, “Drug companies and healthcare providers will …